NCT 03165734 Brief Summary This study (study ID PAC203 North America; PAC303…
Read more arrow_forwardNCT 04857372 Brief Summary The purpose of this study is to characterize…
Read more arrow_forwardNCT 04801095 Brief Summary This study evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics,…
Read more arrow_forwardNCT 05415072 Brief Summary This is a FIH, phase I/II, open…
Read more arrow_forwardNCT 05182931 Brief Summary This prospective, multi-centre, open label, non-randomised phase II…
Read more arrow_forwardNCT 04923048 Brief Summary This is a Phase 1/2 study of GB261…
Read more arrow_forwardNCT 04923048 Brief Summary This is a Phase 1/2 study of GB261…
Read more arrow_forwardNCT 05332574 Brief Summary This is a Phase 1/2 study of GB263T…
Read more arrow_forwardNCT 06425991 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 06208150 Brief Summary The purpose of this study is to…
Read more arrow_forward